Patents by Inventor Stephen T. Anderson

Stephen T. Anderson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20190308998
    Abstract: Patterning compositions are described based on organo tin dodecamers with hydrocarbyl ligands, oxo ligands, hydroxo ligands and carboxylato ligands. Alternative dodecamer embodiments have organo tin ligands in place of hydrocarbyl ligands. The organo tin ligands can be incorporated into the dodecamers from a monomer with the structure (RCC)3SnQ, where R is a hydrocarbyl group and Q is a alkyl tin moiety with a carbon bonded to the Sn atom of the monomer and with a Sn bonded as a replacement of a quaternary carbon atom with bonds to 4 carbon atoms. Some or all of the carboxylato and hydroxyl ligands can be replaced with fluoride ions. Good EUV patterning results are obtained with the dodecamer based patterning compositions.
    Type: Application
    Filed: April 4, 2019
    Publication date: October 10, 2019
    Inventors: Brian J. Cardineau, William Earley, Stephen T. Meyers, Kai Jiang, Jeremy T. Anderson
  • Patent number: 10416554
    Abstract: Organometallic solutions have been found to provide high resolution radiation based patterning using thin coatings. The patterning can involve irradiation of the coated surface with a selected pattern and developing the pattern with a developing agent to form the developed image. The patternable coatings may be susceptible to positive-tone patterning or negative-tone patterning based on the use of an organic developing agent or an aqueous acid or base developing agent. The radiation sensitive coatings can comprise a metal oxo/hydroxo network with organic ligands. A precursor solution can comprise an organic liquid and metal polynuclear oxo-hydroxo cations with organic ligands having metal carbon bonds and/or metal carboxylate bonds.
    Type: Grant
    Filed: June 13, 2018
    Date of Patent: September 17, 2019
    Assignee: Inpria Corporation
    Inventors: Stephen T. Meyers, Douglas A. Keszler, Kai Jiang, Jeremy T. Anderson, Andrew Grenville
  • Publication number: 20190137870
    Abstract: Organometallic precursors are described for the formation of high resolution lithography patterning coatings based on metal oxide hydroxide chemistry. The precursor compositions generally comprise ligands readily hydrolysable by water vapor or other OH source composition under modest conditions. The organometallic precursors generally comprise a radiation sensitive organo ligand to tin that can result in a coating that can be effective for high resolution patterning at relatively low radiation doses and is particularly useful for EUV patterning. The precursors compositions are readily processable under commercially suitable conditions. Solution phase processing with in situ hydrolysis or vapor based deposition can be used to form the coatings.
    Type: Application
    Filed: January 3, 2019
    Publication date: May 9, 2019
    Inventors: Stephen T. Meyers, Jeremy T. Anderson, Brian J. Cardineau, Joseph B. Edson, Kai Jiang, Douglas A. Keszler, Alan J. Telecky
  • Publication number: 20180296127
    Abstract: Systems and methods for quantifying the likelihood of the contribution of multiple possible forms of chronic disease to patient reported dyspnea can include the testing protocol having a flow/volume loop, performed at rest, flowed by the measurement of cardiopulmonary exercise gas exchange variables during rest, exercise and recovery as unique data sets. The data sets are analyzed using feature extraction steps to produce a pictorial image consisting of disease silos displaying the likelihood of the contribution of various chronic diseases to patient reported dyspnea. In some embodiments, the silos are split into subclass silos. In some embodiments, multiple chronic disease indexes are used to differentiate between sub-types of a particular chronic disease (e.g., differentiating WHO 1 PH from WHO 2 or WHO 3 PH). Test results are plotted serially to asses to provide feedback to the physician on the efficacy of therapy provided to the patient.
    Type: Application
    Filed: June 18, 2018
    Publication date: October 18, 2018
    Inventors: Stephen T. ANDERSON, Dean J. MACCARTER, David M. ANDERSON, Andrew HOFMEISTER
  • Publication number: 20180296126
    Abstract: Systems and methods for estimating a ventilatory threshold for a patient and estimating likelihood of pulmonary arterial hypertension are provided. An example method includes determining ratios of minute ventilation to rate of oxygen uptake based on breath-by-breath data for a patient. The example method also includes determining a ventilatory threshold based upon the determined ratios and determining a score based upon an end-tidal partial pressure of carbon dioxide (PetCO2) value at the determined ventilatory threshold and a minute ventilation/carbon dioxide production relationship (VE/VCO2) value at the determined ventilatory threshold. The method also includes using the score to estimate a likelihood that the patient has pulmonary arterial hypertension and causing the estimated likelihood to be displayed on a user interface.
    Type: Application
    Filed: April 16, 2018
    Publication date: October 18, 2018
    Inventors: David M. ANDERSON, Stephen T. ANDERSON, Dean J. MACCARTER
  • Patent number: 10010264
    Abstract: Systems and methods for quantifying the likelihood of the contribution of multiple possible forms of chronic disease to patient reported dyspnea can include the testing protocol having a flow/volume loop, performed at rest, flowed by the measurement of cardiopulmonary exercise gas exchange variables during rest, exercise and recovery as unique data sets. The data sets are analyzed using feature extraction steps to produce a pictorial image consisting of disease silos displaying the likelihood of the contribution of various chronic diseases to patient reported dyspnea. In some embodiments, the silos are split into subclass silos. In some embodiments, multiple chronic disease indexes are used to differentiate between sub-types of a particular chronic disease (e.g., differentiating WHO 1 PH from WHO 2 or WHO 3 PH). Test results are plotted serially to asses to provide feedback to the physician on the efficacy of therapy provided to the patient.
    Type: Grant
    Filed: July 25, 2014
    Date of Patent: July 3, 2018
    Assignee: Shape Medical Systems, Inc.
    Inventors: Stephen T. Anderson, Dean J. MacCarter, David M. Anderson, Andrew Hofmeister
  • Publication number: 20160151016
    Abstract: A method of pattern recognition for defining aerobic HR training zones measured during incremental cardiopulmonary exercise testing wherein such HR training zones are derived from distinct points in the incremental exercise response for % fat, % CHO, and PetCO2. Also disclosed is a method for providing feedback to the exercising subject indicating the % time the subject exercised in each of the zones using recorded HR data from each workout.
    Type: Application
    Filed: June 18, 2014
    Publication date: June 2, 2016
    Inventors: Stephen T. Anderson, David Anderson, Bruce D. Johnson, Dianna Orr
  • Publication number: 20150032018
    Abstract: Systems and methods for quantifying the likelihood of the contribution of multiple possible forms of chronic disease to patient reported dyspnea can include the testing protocol having a flow/volume loop, performed at rest, flowed by the measurement of cardiopulmonary exercise gas exchange variables during rest, exercise and recovery as unique data sets. The data sets are analyzed using feature extraction steps to produce a pictorial image consisting of disease silos displaying the likelihood of the contribution of various chronic diseases to patient reported dyspnea. In some embodiments, the silos are split into subclass silos. In some embodiments, multiple chronic disease indexes are used to differentiate between sub-types of a particular chronic disease (e.g., differentiating WHO 1 PH from WHO 2 or WHO 3 PH). Test results are plotted serially to asses to provide feedback to the physician on the efficacy of therapy provided to the patient.
    Type: Application
    Filed: July 25, 2014
    Publication date: January 29, 2015
    Inventors: Stephen T. Anderson, Dean J. MacCarter, David M. Anderson
  • Patent number: 8775093
    Abstract: A method employing pattern recognition techniques for identifying the functional status of patients with Pulmonary Hypertension is described. This method describes a process by which sets of cardiopulmonary exercise gas exchange variables are measured during rest, exercise and recovery and stored as unique data sets. The data sets are then analyzed by a series of feature extraction steps, yielding a multi-parametric index (MPIPH) which reflects the current functional status of a patient. The method also employs a description scheme that provides a graphical image that juxtaposes the measured value of MPI to a reference classification system. An additional description scheme provides a trend plot of MPI values measured on a patient over time to provide feedback to the physician on the efficacy of therapy provided to the patient.
    Type: Grant
    Filed: September 25, 2009
    Date of Patent: July 8, 2014
    Assignee: Shape Medical Systems, Inc.
    Inventors: Stephen T. Anderson, Dean J. MacCarter
  • Patent number: 8768463
    Abstract: A method of data management for optimizing the patient outcome from the provision of cardiac resynchronization therapy (CRT) is described. A regression equation is constructed using 3 data points on a plot of AV delay vs. HR. The x-axis consist of the three points consist of resting HR, HR at the optimal AV delay value during light exercise, and the upper tracking or paced HR. The y-values associated with the three points consist of the AV delay values computed using an equation for ventricular filling time and the optimally determined AV delay value. Also described is a process for determining the sensed to paced AV delay offset. The combined processes yield 4 (the three constant values in the polynomial regression equation Y=b2X2+b1X+a and the sensed to paced AV delay offset) which can be stored on the patient's pacemaker for determining dynamically the AV delay value which is physiologically fine-tuned for each patient from resting HR to the upper tracking or paced HR.
    Type: Grant
    Filed: November 11, 2010
    Date of Patent: July 1, 2014
    Assignee: Shape Medical Systems, Inc.
    Inventors: Stephen T. Anderson, Dean J. MacCarter
  • Publication number: 20140163397
    Abstract: A gas exchange testing system has an apparatus for delivery of an auxiliary gas during a gas exchange test. Measurements representing physiological parameters of a patient are made during the gas exchange test. The auxiliary gas is delivered so that a gas exchange test can be performed on a patient who requires auxiliary gas. Additionally, the auxiliary gas is delivered so that gas exchange testing can determine if the auxiliary gas is beneficial and which concentration of the auxiliary gas is most beneficial. A testing process compares measurements under a condition where the auxiliary gas is delivered and under a condition where it is not delivered. Another testing process compares measurements under a condition where one auxiliary gas is delivered and under a condition where a different auxiliary gas is delivered.
    Type: Application
    Filed: December 6, 2013
    Publication date: June 12, 2014
    Applicant: Shape Medical Systems, LLC
    Inventors: Stephen T. Anderson, Dean J. MacCarter, Bruce D. Johnson, Tyler J. Bahr
  • Patent number: 8630811
    Abstract: A method of pattern recognition for classifying the functional status of patients with chronic disease comprising characterizing the functional status based on a multivariable index (MVI) scoring system wherein the MVI is computed by summing a plurality of individual variable values as individual variable indexes (IVI) and dividing the sum by the number of variables and wherein the plurality of IVI includes rest PetCO2, ?PetCO2, SaO2, QUES, Ve/VCO2 slope and Pcap and wherein each IVI is given an equivalent value of <1.00 to >=4.00, the number increasing with increasing severity yielding an MVI value ranging from <1.00 to >=4.00, normal to severe-very severe.
    Type: Grant
    Filed: June 26, 2012
    Date of Patent: January 14, 2014
    Assignee: Shape Medical Systems, Inc.
    Inventors: Stephen T. Anderson, Dean J. MacCarter, Bruce D. Johnson
  • Publication number: 20120265447
    Abstract: A method of pattern recognition for classifying the functional status of patients with chronic disease comprising characterizing the functional status based on a multivariable index (MVI) scoring system wherein the MVI is computed by summing a plurality of individual variable values as individual variable indexes (IVI) and dividing the sum by the number of variables and wherein the plurality of IVI includes rest PetCO2, ?PetCO2, SaO2, QUES, Ve/VCO2 slope and Pcap and wherein each IVI is given an equivalent value of <1.00 to >=4.00, the number increasing with increasing severity yielding an MVI value ranging from <1.00 to >=4.00, normal to severe-very severe.
    Type: Application
    Filed: June 26, 2012
    Publication date: October 18, 2012
    Inventors: Stephen T. Anderson, Dean J. MacCarter, Bruce D. Johnson
  • Publication number: 20120123493
    Abstract: A method of data management for optimizing the patient outcome from the provision of cardiac resynchronization therapy (CRT) is described. A regression equation is constructed using 3 data points on a plot of AV delay vs. HR. The x-axis consist of the three points consist of resting HR, HR at the optimal AV delay value during light exercise, and the upper tracking or paced HR. The y-values associated with the three points consist of the AV delay values computed using an equation for ventricular filling time and the optimally determined AV delay value. Also described is a process for determining the sensed to paced AV delay offset. The combined processes yield 4 (the three constant values in the polynomial regression equation Y=b2X2+b1X+a and the sensed to paced AV delay offset) which can be stored on the patient's pacemaker for determining dynamically the AV delay value which is physiologically fine-tuned for each patient from resting HR to the upper tracking or paced HR.
    Type: Application
    Filed: November 11, 2010
    Publication date: May 17, 2012
    Applicant: Shape Medical Systems, Inc.
    Inventors: Stephen T. Anderson, Dean J. MacCarter
  • Patent number: 7713211
    Abstract: A method of data management for optimizing the patient outcome from the provision of external counterpulsation (ECP) therapy is described. This method describes a process by which sets of dynamic cardiopulmonary dependent variables are measured during steady-state conditions, displayed, and translated into quantitative and qualitative measurements while the independent variables of ECP, cuff inflation duration and cuff inflation pressure settings of ECP systems, are altered by a physician. In combination with visual observation and computer-assisted ranking of the dependent variables, a physician can utilize the resulting information to render decisions on the optimal choice of the independent variables. The method will enable physicians to collect, view, track and manage complicated data using well-understood visualization techniques to better understand the consequences, acutely and chronically, of their therapeutic actions in general, and of their provision of ECP therapy in particular.
    Type: Grant
    Filed: July 12, 2004
    Date of Patent: May 11, 2010
    Assignee: Shape Medical Systems, Inc.
    Inventors: Stephen T. Anderson, Dean J. MacCarter
  • Publication number: 20100016750
    Abstract: A method employing pattern recognition techniques for identifying the functional status of patients with Pulmonary Hypertension is described. This method describes a process by which sets of cardiopulmonary exercise gas exchange variables are measured during rest, exercise and recovery and stored as unique data sets. The data sets are then analyzed by a series of feature extraction steps, yielding a multi-parametric index (MPIPH) which reflects the current functional status of a patient. The method also employs a description scheme that provides a graphical image that juxtaposes the measured value of MPI to a reference classification system. An additional description scheme provides a trend plot of MPI values measured on a patient over time to provide feedback to the physician on the efficacy of therapy provided to the patient.
    Type: Application
    Filed: September 25, 2009
    Publication date: January 21, 2010
    Applicant: Shape Medical Systems, Inc.
    Inventors: Stephen T. Anderson, Dean J. MacCarter
  • Publication number: 20090076347
    Abstract: A method employing pattern recognition techniques for identifying the functional status of patients with chronic disease is described. This method describes a process by which sets of cardiopulmonary exercise gas exchange variables are measured during rest, exercise and recovery and stored as unique data sets. The data sets are then analyzed by a series of feature extraction steps, yielding a multi-parametric index (MPI) which reflects the current functional status of a patient. The method also employs a description scheme that provides a graphical image that juxtaposes the measured value of MPI to a reference classification system. An additional description scheme provides a trend plot of MPI values measured on a patient over time to provide feedback to the physician on the efficacy of therapy provided to the patient. The method will enable physicians to gather, view, and track complicated data using well-understood visualization techniques to better understand the consequences of their therapeutic actions.
    Type: Application
    Filed: September 12, 2008
    Publication date: March 19, 2009
    Applicant: SHAPE MEDICAL SYSTEMS, INC.
    Inventors: Stephen T. Anderson, Dean J. MacCarter, Ross Arena
  • Patent number: 7225022
    Abstract: A method of data management for optimizing the patient outcome from the provision of cardiac resynchronization therapy (CRT) is described. This method describes a process by which sets of dynamic cardiopulmonary dependent variables are measured during steady-state conditions, displayed, and translated into quantitative and qualitative measurements while the independent variables of CRT, device lead placement and atrial-ventricular and interventricular delay settings of bi-ventricular pacemaker systems, are altered by a physician. In combination with visual observation and computer-assisted ranking of the dependent variables, a physician can utilize the resulting information to render decisions on the optimal choice of the independent variables.
    Type: Grant
    Filed: March 11, 2004
    Date of Patent: May 29, 2007
    Assignee: CRA Associates, Ltd.
    Inventors: Stephen T. Anderson, Dean J. MacCarter
  • Publication number: 20040260185
    Abstract: A method of data management for assessing a patient's autonomic balance, risk of death, and the patient's response to therapy in terms of these assessments is described. This method describes a process by which a set of “raw variables” (RV) are translated into one or more of a new variable, defined as an Mortality Prediction Index, (MPI) that quantifies the patient's cardiovascular reflex control and risk of death. The translated variables are representative of both central and peripheral chemo receptivity, baroreflexes, and peripheral ergo receptors, which, in turn, provide the measurement of sympathovagal, or autonomic, balance. The process of selection and measurement of the MPI, and thus the sympathetic and parasympathetic components of autonomic balance at rest and during dynamic, isotonic exercise and recovery is described. The invention will further define risk of death using a Kaplan-Meier Plot for certain translated variables.
    Type: Application
    Filed: July 12, 2004
    Publication date: December 23, 2004
    Applicant: Cortex Biophysik GmbH
    Inventors: Stephen T. Anderson, Dean J. MacCarter
  • Publication number: 20040254482
    Abstract: A method of data management for optimizing the patient outcome from the provision of external counterpulsation (ECP) therapy is described. This method describes a process by which sets of dynamic cardiopulmonary dependent variables are measured during steady-state conditions, displayed, and translated into quantitative and qualitative measurements while the independent variables of ECP, cuff inflation duration and cuff inflation pressure settings of ECP systems, are altered by a physician. In combination with visual observation and computer-assisted ranking of the dependent variables, a physician can utilize the resulting information to render decisions on the optimal choice of the independent variables. The method will enable physicians to collect, view, track and manage complicated data using well-understood visualization techniques to better understand the consequences, acutely and chronically, of their therapeutic actions in general, and of their provision of ECP therapy in particular.
    Type: Application
    Filed: July 12, 2004
    Publication date: December 16, 2004
    Applicant: CRA Associates, LTD
    Inventors: Stephen T. Anderson, Dean J. MacCarter